Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Phase 2 Recruiting 43 enrolled City of Hope Medical Center National Cancer Institute (NCI) · collab

NaSingle-groupOpen-labelTreatment

Summary

This phase IIa trial studies the side effects of abemaciclib monotherapy in treating patients age 70 years and older with hormone receptor positive, HER2 negative breast cancer that has spread to other places in the body.

Timeline

Start: 2020-03-25
Primary completion: 2026-08-21
Completion: 2026-08-21

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Abemaciclib	Small molecule	—	Oral

Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.

Summary

Timeline

Drugs

Indications